Side effects of weight-loss injections: what is common and when to call the doctor

The most common side effects of weight-loss injections are digestive — nausea, diarrhoea, vomiting, constipation and abdominal pain — they appear mainly in the first weeks and with each dose increase, and they usually ease over time. The reactions that call for immediate contact with the doctor are few and recognisable: severe abdominal pain that spreads to the back, vomiting that does not settle, signs of severe dehydration and signs of an allergic reaction.

This article does not discuss doses and does not tell you what to do with your treatment schedule. It says what is described in the approved documents, so that you know what to expect and what not.

What does "common" mean in a package leaflet?

The categories in the approved documents are not impressions; they are defined intervals. They are worth knowing, because they completely change the way you read a list of side effects.

A "rare" reaction therefore occurs in fewer than one person in a thousand. That does not mean it does not matter — acute pancreatitis is rare, and it is exactly the reason why severe abdominal pain calls for an urgent consultation.

What is common and passes on its own?

Digestive reactions dominate the list for all the products in the class. The product information published by the European Medicines Agency for Mounjaro, Ozempic and Wegovy reports them as the most common:

• nausea — typically at the start and after a dose increase;
• diarrhoea;
• vomiting;
• constipation;
• abdominal pain of mild or moderate intensity;
• indigestion, burping, bloating;
• decreased appetite — which is, in fact, part of the mechanism;
• tiredness;
• injection-site reactions.

The common pattern: they appear in the first weeks, are more intense after each dose increase and ease as the body adapts. That does not mean they have to be endured in silence — if they interfere with daily life, the doctor who prescribed the treatment needs to know, because they have options that you do not.

A side effect of these reactions that is easy to overlook: they reduce fluid intake. When you eat less, the water that came from food disappears too, and nausea makes a glass of water feel like an effort. What can be done at home, we have set out in the article on hydration and food intake.

Does Ozempic have different side effects from Mounjaro?

Not fundamentally. In both, the profile is dominated by digestive reactions — nausea, diarrhoea, vomiting, constipation, abdominal pain — with the same onset at the start and after a dose increase.

The notable difference lies in the warnings, not in the list of reactions: the product information for Ozempic contains a specific warning about the risk of dehydration associated with gastrointestinal reactions, with extra caution in patients with impaired kidney function, and one about the temporary worsening of diabetic retinopathy when blood glucose falls rapidly.

For each product, the approved document is the only reference that counts — not a comparison written by someone else, including us.

What should not be waited out at home?

The following are not "starting reactions". Contact your doctor or the emergency services:

• severe and persistent abdominal pain, especially if it spreads to the back and comes with vomiting — it may be a sign of acute pancreatitis;
• pain in the upper right part of the abdomen, fever, yellowing of the skin or eyes — these may be signs of gallbladder involvement;
• repeated vomiting with an inability to keep fluids down;
• signs of severe dehydration — severe dizziness, fainting, no urine for several hours, confusion;
• signs of an allergic reaction — a widespread rash, swelling of the face, lips or tongue, difficulty breathing;
• signs of hypoglycaemia if you also take insulin or sulphonylureas — sweating, shaking, confusion, palpitations;
• changes in vision, in people with diabetic retinopathy.

The product information for Ozempic includes a specific warning about the risk of dehydration associated with gastrointestinal side effects, with extra caution in patients with impaired kidney function. It is one more reason not to treat persistent vomiting as a mere inconvenience.

What is known about long-term side effects?

Less than online discussions would suggest, and that is worth saying directly.

The authorisation trials followed participants for 68-72 weeks. There are safety data over longer periods from use in type 2 diabetes, where these substances have been used for several years, but the question "what happens after ten years of treatment for weight" does not yet have an answer based on trials of the same quality.

What is documented and monitored: the risk of acute pancreatitis, gallbladder disorders, the course of diabetic retinopathy in people with diabetes and, for some products, the warning related to a history of medullary thyroid carcinoma — which is why the latter are contraindications, not just precautions. The complete list is in the article on contraindications.

The honest position: the class has a well-characterised safety profile in the medium term, and in the very long term the data are still accumulating. Anyone who presents you with certainties in either direction — "completely safe" or "dangerous" — is going beyond what can be supported.

Can I prevent the digestive reactions?

Partly, and without guarantees. The measures with the best ratio of effort to effect, none of them a medical intervention:

• smaller, more frequent portions instead of large meals;
• stopping the meal at the first sign of fullness, not when the plate is empty;
• fewer very fatty or very spicy foods during periods of nausea;
• fluids between meals, not during them;
• gentle movement after a meal instead of lying down.

Anything else — including medication for nausea — is discussed with the doctor who prescribed the treatment. We do not recommend anything for you to take and we do not tell you to change anything in your schedule.

In short

• The most common side effects are digestive, appear mainly in the first weeks and after a dose increase, and usually ease over time.
• In the approved documents, "common" means between 1 in 100 and 1 in 10 people, and "rare" means fewer than 1 in 1,000 — the categories are defined intervals, not estimates.
• Severe abdominal pain that spreads to the back, vomiting that does not settle and signs of severe dehydration call for immediate contact with the doctor or an urgent consultation.
• Digestive reactions indirectly reduce fluid intake, because part of it came from food and because nausea makes drinking difficult.
• The medium-term safety profile is well characterised; the very long-term data in the weight-management indication are still accumulating.

This article is for information only and does not replace a medical consultation. Side effects are reported to the doctor who prescribed the treatment. In an emergency, call 112 (the emergency number in Romania and across the EU).